Cardinal Health to sell off its Cordis device division in $1B ... | 合法醫療器材資訊網

2021年3月15日—Aftersixyears,CardinalHealthisdroppingitsCordismedicaldevicedivision,makersofcardiovascularcathetersanddiagnostichardware,ina ...

After six years, Cardinal Health is dropping its Cordis medical device division, makers of cardiovascular catheters and diagnostic hardware, in a $1 billion deal with private equity firm Hellman & Friedman.

The healthcare services and distribution giant previously spent $1.9 billion[1] to acquire Cordis from Johnson & Johnson in 2015, following months of rumors[2], with the hope of using it to grow its global footprint and deliver a broader device portfolio.

However, establishing the infrastructure needed to do so became more expensive[3] than Cardinal Health anticipated—with large write-offs by 2018 due to expiring product inventories plus difficulties in optimizing Cordis’ manufacturing plants.

"Our decision to divest Cordis demonstrates our disciplined approach to evaluating our portfolio and focusing our resources in our strategic growth areas where we are a...